North China Pharmaceutical Company.Ltd (SHA:600812)

China flag China · Delayed Price · Currency is CNY
5.79
-0.22 (-3.66%)
Mar 10, 2026, 2:04 PM CST
-7.06%
Market Cap 10.31B
Revenue (ttm) 9.79B
Net Income (ttm) 183.03M
Shares Out 1.72B
EPS (ttm) 0.11
PE Ratio 56.72
Forward PE n/a
Dividend 0.03 (0.54%)
Ex-Dividend Date n/a
Volume 85,568,647
Average Volume 21,128,053
Open 5.90
Previous Close 6.01
Day's Range 5.76 - 5.94
52-Week Range 5.32 - 7.46
Beta 0.47
RSI 71.06
Earnings Date Apr 18, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 10,000
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600812
Full Company Profile

Financial Performance

In 2024, SHA:600812's revenue was 9.87 billion, a decrease of -2.48% compared to the previous year's 10.12 billion. Earnings were 126.99 million, an increase of 2496.79%.

Financial Statements

News

There is no news available yet.